Hematological Malignancies

A new strategy for adult T-cell leukemia treatment targeting glycogen synthase kinase-3β

Publications / Dan

A new strategy for adult T-cell leukemia treatment targeting glycogen synthase kinase-3β Read More »

The tumor suppressor protein TRAF3 modulates GSK3 activity and susceptibility of B lymphoma cells to GSK3 inhibition

Publications / Dan

The tumor suppressor protein TRAF3 modulates GSK3 activity and susceptibility of B lymphoma cells to GSK3 inhibition Read More »

2020-AACR-9-ING-41, a GSK-3β-selective small molecule inhibitor, in combination with ruxolitinib in JAK2617F primary myelofibrosis

Publications / Dan

2020-AACR-9-ING-41, a GSK-3β-selective small molecule inhibitor, in combination with ruxolitinib in JAK2617F primary myelofibrosis Read More »

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Publications / lsc-webmaster

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma Read More »

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents

Publications / lsc-webmaster

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents Read More »

Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model

Publications / Dan

Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model Read More »

Glycogen synthase kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death

Publications / Dan

Glycogen synthase kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death Read More »

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy

Publications / lsc-webmaster

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy Read More »

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells

Publications / lsc-webmaster

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells Read More »